Author:
Elm’hadi Choukri,Tanz Rachid,Khmamouche Mohamed Reda,Toreis Mehdi,Mahfoud Tarik,Slimani Khaoula Alaoui,Errihani Hassan,Ichou Mohammed
Publisher
Springer Science and Business Media LLC
Reference16 articles.
1. Chew L, Chuen VS (2009) Cutaneous reactions associated with weekly docetaxel administration. J Oncol Pharm Pract 15:29–34. doi: 10.1177/1078155208096111 (Epub 2008 Aug 27)
2. Drori S, Eytan GD, Assaraf YG (1995) Potentiation of anticancer-drug cytotoxicity by multidrug-resistance chemosensitizers involves alterations in membrane fluidity leading to increased membrane permeability. Eur J Biochem 228:1020–1029
3. Décret n° 2-12-198 du 21 rejeb 1433 (12 juin 2012) relatif à la bioéquivalence des médicaments génériques. http://www.sante.gov.ma/Reglementation/MedPharma . Accessed 06 Oct 2015
4. Food and Drug Administration (2012) Approved drug products with therapeutic equivalence evaluations (Orange Book), 32nd edn. US Department of Health and Human Services, Washington, DC, pp vi–vii
5. Garrido-Siles M, Arenas-Villafranca JJ, Pérez-Ruiz E, de Linares Fernández MF, Tortajada B, Rivas-Ruiz F, Faus V (2015) New cutaneous toxicities with generic docetaxel: Are the excipients guilty? Support Care Cancer 23(7):1917–1923. doi: 10.1007/s00520-014-2499-2 (Epub 2014 Dec 10)
Cited by
17 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献